InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by Burek Julie, Chief Financial Officer. Director active across 1 company, notably Voyager Therapeutics, Inc.. Cumulatively, 9 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €23k. Activity tracked since 26 November 2021. The latest transaction was disclosed on 21 March 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
2,618 shares@ US$8.290.0085% mcap55.2% of flowCommon StockSEC:0001104659-22-037151:0
789 shares@ US$3.550.0011% mcap6.9% of flowCommon StockSEC:0001104659-22-025669:0
361 shares@ US$3.360.0005% mcap3.0% of flowCommon StockSEC:0001104659-22-023833:0
10,000 shares0Common StockSEC:0001104659-22-005023
10,000 shares0Common StockSEC:0001104659-22-005023:0
3,063 shares@ US$2.30100.0% of flowCommon StockSEC:0001104659-22-004515
3,063 shares@ US$2.300.0027% mcap17.5% of flowCommon StockSEC:0001104659-22-004515:0
13,500 shares0Common StockSEC:0001104659-21-144995
13,500 shares0Common StockSEC:0001104659-21-144995:0
9 of 9 declarations
About Burek Julie
Julie Burek is Vice President and Chief Financial Officer at Voyager Therapeutics, Inc. She oversees the company's financial operations and is responsible for financial planning and risk management. Her expertise is crucial in ensuring the financial health of the company.
